FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
'Even with some variation, there's still reasonably good protection'
Stay updated with breaking news from Both Moderna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'Even with some variation, there's still reasonably good protection'
Moderna’s new shot offers the potential of a longer shelf life and is one component of its combination vaccine targeting Covid and the flu.
Moderna's new shot offers the potential of a longer shelf life and is one component of its combination vaccine targeting Covid and the flu.
Scientists explore the potential of a technique that enabled the rapid development of the first Covid-19 vaccines and which holds immense potential in combating other diseases like cancer, the flu, HIV and autoimmune conditions
Metro Public Health Department ordered fraction of shots compared to previous boosters